Loading...

Irene Litvan

TitleProfessor In Residence
InstitutionUniversity of California San Diego
DepartmentNeurosciences
Address9500 Gilman Drive #0886
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Moreno GM, Gandhi R, Lessig SL, Wright B, Litvan I, Nahab FB. Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine. Neurology. 2018 Sep 26. PMID: 30258020.
      View in: PubMed
    2. Lopez FV, Split M, Filoteo JV, Litvan I, Moore RC, Pirogovsky-Turk E, Liu L, Lessig S, Schiehser DM. Does the Geriatric Depression Scale measure depression in Parkinson's disease? Int J Geriatr Psychiatry. 2018 Sep 25. PMID: 30251374.
      View in: PubMed
    3. Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests. Mov Disord. 2018 Sep 14. PMID: 30216541.
      View in: PubMed
    4. Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schäffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB. Movement disorder society criteria for clinically established early Parkinson's disease. Mov Disord. 2018 Aug 25. PMID: 30145841.
      View in: PubMed
    5. Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D. Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2018 Aug 25. PMID: 30145797.
      View in: PubMed
    6. Yuan SH, Hiramatsu N, Liu Q, Sun XV, Lenh D, Chan P, Chiang K, Koo EH, Kao AS, Litvan I, Lin JH. Tauopathy-Associated PERK Alleles are Functional Hypomorphs that Increase Neuronal Vulnerability to ER Stress. Hum Mol Genet. 2018 Aug 21. PMID: 30137327.
      View in: PubMed
    7. Chahine LM, Urbe L, Caspell-Garcia C, Aarsland D, Alcalay R, Barone P, Burn D, Espay AJ, Hamilton JL, Hawkins KA, Lasch S, Leverenz JB, Litvan I, Richard I, Siderowf A, Coffey CS, Simuni T, Weintraub D. Cognition among individuals along a spectrum of increased risk for Parkinson's disease. PLoS One. 2018; 13(8):e0201964. PMID: 30125297.
      View in: PubMed
    8. Iddi S, Li D, Aisen PS, Rafii MS, Litvan I, Thompson WK, Donohue MC. Estimating the Evolution of Disease in the Parkinson's Progression Markers Initiative. Neurodegener Dis. 2018 Aug 08; 18(4):173-190. PMID: 30089306.
      View in: PubMed
    9. Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathol. 2018 Jun 20. PMID: 29926172.
      View in: PubMed
    10. Kelley KD, Checkoway H, Hall DA, Reich SG, Cunningham C, Litvan I. Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans. Front Neurol. 2018; 9:474. PMID: 29973911.
      View in: PubMed
    11. Bluett B, Banks S, Cordes D, Bayram E, Mishra V, Cummings J, Litvan I. Neuroimaging and neuropsychological assessment of freezing of gait in Parkinson's disease. Alzheimers Dement (N Y). 2018; 4:387-394. PMID: 30211293.
      View in: PubMed
    12. Shoeibi A, Olfati N, Litvan I. Preclinical, phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy. Expert Opin Investig Drugs. 2018 Apr; 27(4):349-361. PMID: 29602288.
      View in: PubMed
    13. Litvan I, Kieburtz K, Tröster AI, Aarsland D. Strengths and challenges in conducting clinical trials in Parkinson's disease mild cognitive impairment. Mov Disord. 2018 Apr; 33(4):520-527. PMID: 29573469.
      View in: PubMed
    14. Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment. Mov Disord. 2018 Apr; 33(4):503-510. PMID: 29488270.
      View in: PubMed
    15. Park HK, Ilango S, Charriez CM, Checkoway H, Riley D, Standaert DG, Bordelon Y, Shprecher DR, Reich SG, Hall D, Kluger B, Marras C, Jankovic J, Dubinsky R, Litvan I. Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study. Mov Disord. 2018 Mar; 33(3):468-472. PMID: 29460982.
      View in: PubMed
    16. Weintraub D, Hamilton JL, Eberling J, Litvan I. At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease. Mov Disord. 2018 Apr; 33(4):501-502. PMID: 29418018.
      View in: PubMed
    17. Marras C, Cunningham CR, Hou J, Proudfoot J, Standaert DG, Juncos J, Riley D, Reich SG, Hall D, Kluger B, Bordelon Y, Shprecher DR, Litvan I. Anti-inflammatory drug use and progressive supranuclear palsy. Parkinsonism Relat Disord. 2018 Mar; 48:89-92. PMID: 29307562.
      View in: PubMed
    18. Rajagopalan R, Litvan I, Jung TP. Fall Prediction and Prevention Systems: Recent Trends, Challenges, and Future Research Directions. Sensors (Basel). 2017 Nov 01; 17(11). PMID: 29104256.
      View in: PubMed
    19. Gerstenecker A, Roberson ED, Schellenberg GD, Standaert DG, Shprecher DR, Kluger BM, Litvan I. Genetic influences on cognition in progressive supranuclear palsy. Mov Disord. 2017 Dec; 32(12):1764-1771. PMID: 29076559.
      View in: PubMed
    20. Shoeibi A, Litvan I. Prominent tongue and jaw tremor in a patient with probable Progressive Supranuclear Palsy. Mov Disord Clin Pract. 2018 Jan-Feb; 5(1):99-100. PMID: 30271811.
      View in: PubMed
    21. Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I, Roberson ED, Seeley WW, Grinberg LT, Kramer JH, Miller BL, Pressman P, Nasrallah I, Baker SL, Gomperts SN, Johnson KA, Grossman M, Jagust WJ, Boxer AL, Rabinovici GD. 18 F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study. Ann Neurol. 2017 Oct; 82(4):622-634. PMID: 28980714.
      View in: PubMed
    22. Harrington DL, Shen Q, Castillo GN, Filoteo JV, Litvan I, Takahashi C, French C. Aberrant Intrinsic Activity and Connectivity in Cognitively Normal Parkinson's Disease. Front Aging Neurosci. 2017; 9:197. PMID: 28674492.
      View in: PubMed
    23. Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol. 2017 Jul; 16(7):552-563. PMID: 28653647.
      View in: PubMed
    24. Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ. Mild cognitive impairment as a risk factor for Parkinson's disease dementia. Mov Disord. 2017 Jul; 32(7):1056-1065. PMID: 28605056.
      View in: PubMed
    25. Caspell-Garcia C, Simuni T, Tosun-Turgut D, Wu IW, Zhang Y, Nalls M, Singleton A, Shaw LA, Kang JH, Trojanowski JQ, Siderowf A, Coffey C, Lasch S, Aarsland D, Burn D, Chahine LM, Espay AJ, Foster ED, Hawkins KA, Litvan I, Richard I, Weintraub D. Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease. PLoS One. 2017; 12(5):e0175674. PMID: 28520803.
      View in: PubMed
    26. Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU. Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord. 2017 Jul; 32(7):995-1005. PMID: 28500752.
      View in: PubMed
    27. Whitwell JL, Höglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe LI, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, Rowe JB, Stamelou M, Josephs KA. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be? Mov Disord. 2017 Jul; 32(7):955-971. PMID: 28500751.
      View in: PubMed
    28. Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017 Jun; 32(6):853-864. PMID: 28467028.
      View in: PubMed
    29. Holiday KA, Pirogovsky-Turk E, Malcarne VL, Filoteo JV, Litvan I, Lessig SL, Song D, Schiehser DM. Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease. Mov Disord Clin Pract. 2017 Sep-Oct; 4(5):717-723. PMID: 28435846.
      View in: PubMed
    30. Kelley KD, Peavy G, Edland S, Rogers W, Riley DE, Bordelon Y, Standaert D, Reich SG, Litvan I. The Role of Stress as a Risk Factor for Progressive Supranuclear Palsy. J Parkinsons Dis. 2017; 7(2):377-383. PMID: 28409749.
      View in: PubMed
    31. Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J. Understanding falls in progressive supranuclear palsy. Parkinsonism Relat Disord. 2017 Feb; 35:75-81. PMID: 28007518.
      View in: PubMed
    32. Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, Schuff N, Rabinovici GD, Kramer JH, Jack CR, Miller BL, Rosen HJ, Boxer AL. Progression of brain atrophy in PSP and CBS over 6 months and 1 year. Neurology. 2016 Nov 08; 87(19):2016-2025. PMID: 27742814.
      View in: PubMed
    33. Pirogovsky-Turk E, Moore RC, Filoteo JV, Litvan I, Song DD, Lessig SL, Schiehser DM. Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study. Am J Geriatr Psychiatry. 2017 Mar; 25(3):279-289. PMID: 27838315.
      View in: PubMed
    34. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. Abolishing the 1-year rule: How much evidence will be enough? Mov Disord. 2016 11; 31(11):1623-1627. PMID: 27666574.
      View in: PubMed
    35. Nandipati S, Litvan I. Environmental Exposures and Parkinson's Disease. Int J Environ Res Public Health. 2016 09 03; 13(9). PMID: 27598189.
      View in: PubMed
    36. Zhang Y, Walter R, Ng P, Luong PN, Dutt S, Heuer H, Rojas-Rodriguez JC, Tsai R, Litvan I, Dickerson BC, Tartaglia MC, Rabinovici G, Miller BL, Rosen HJ, Schuff N, Boxer AL. Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study. PLoS One. 2016; 11(6):e0157218. PMID: 27310132.
      View in: PubMed
    37. Schiehser DM, Filoteo JV, Litvan I, Pirogovsky-Turk E, Lessig SL, Song DS. Cognitive functioning in individuals with Parkinson's disease and traumatic brain injury: A longitudinal study. Parkinsonism Relat Disord. 2016 Sep; 30:58-61. PMID: 27260791.
      View in: PubMed
    38. Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF. a-synuclein genetic variability: A biomarker for dementia in Parkinson disease. Ann Neurol. 2016 Jun; 79(6):991-9. PMID: 27091628.
      View in: PubMed
    39. Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, Eskofier BM, Merola A, Horak F, Lang AE, Reilmann R, Giuffrida J, Nieuwboer A, Horne M, Little MA, Litvan I, Simuni T, Dorsey ER, Burack MA, Kubota K, Kamondi A, Godinho C, Daneault JF, Mitsi G, Krinke L, Hausdorff JM, Bloem BR, Papapetropoulos S. Technology in Parkinson's disease: Challenges and opportunities. Mov Disord. 2016 09; 31(9):1272-82. PMID: 27125836.
      View in: PubMed
    40. Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, Olanow CW, Poewe W, Stern M. The new definition and diagnostic criteria of Parkinson's disease. Lancet Neurol. 2016 May; 15(6):546-8. PMID: 27302120.
      View in: PubMed
    41. Besser LM, Litvan I, Monsell SE, Mock C, Weintraub S, Zhou XH, Kukull W. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease. Parkinsonism Relat Disord. 2016 06; 27:54-60. PMID: 27089852; PMCID: PMC4887313 [Available on 06/01/17].
    42. Brody DM, Litvan I, Warner S, Riley DE, Hall DA, Kluger BM, Shprecher DR, Cunningham CR. Relationship between uric acid levels and progressive supranuclear palsy. Mov Disord. 2016 05; 31(5):663-7. PMID: 26890571.
      View in: PubMed
    43. Litvan I, Lees PS, Cunningham CR, Rai SN, Cambon AC, Standaert DG, Marras C, Juncos J, Riley D, Reich S, Hall D, Kluger B, Bordelon Y, Shprecher DR. Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study. Mov Disord. 2016 05; 31(5):644-52. PMID: 26854325; PMCID: PMC4861658 [Available on 05/01/17].
    44. Arena JE, Weigand SD, Whitwell JL, Hassan A, Eggers SD, Höglinger GU, Litvan I, Josephs KA. Progressive supranuclear palsy: progression and survival. J Neurol. 2016 Feb; 263(2):380-389. PMID: 26705121.
      View in: PubMed
    45. McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W, Tripodis Y, Crary JF, Bieniek KF, Dams-O'Connor K, Alvarez VE, Gordon WA. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016 Jan; 131(1):75-86. PMID: 26667418; PMCID: PMC4698281.
    46. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015 Oct; 30(12):1591-601. PMID: 26474316.
      View in: PubMed
    47. Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. MDS research criteria for prodromal Parkinson's disease. Mov Disord. 2015 Oct; 30(12):1600-11. PMID: 26474317.
      View in: PubMed
    48. Grunho M, Sonies B, Frattali CM, Litvan I. Swallowing disturbances in the corticobasal syndrome. Parkinsonism Relat Disord. 2015 Nov; 21(11):1342-8. PMID: 26456115.
      View in: PubMed
    49. Mata IF, Jang Y, Kim CH, Hanna DS, Dorschner MO, Samii A, Agarwal P, Roberts JW, Klepitskaya O, Shprecher DR, Chung KA, Factor SA, Espay AJ, Revilla FJ, Higgins DS, Litvan I, Leverenz JB, Yearout D, Inca-Martinez M, Martinez E, Thompson TR, Cholerton BA, Hu SC, Edwards KL, Kim KS, Zabetian CP. The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease. Mol Neurodegener. 2015 Sep 24; 10:50. PMID: 26399558; PMCID: PMC4581468.
    50. Pillas M, Selai C, Quinn NP, Lees A, Litvan I, Lang A, Bower J, Burn D, Low P, Schrag A. Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers). Qual Life Res. 2016 Jan; 25(1):81-8. PMID: 26264781.
      View in: PubMed
    51. Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NC, Yoon H, Kim J, Fujioka S, McLean CA, Ghetti B, Spina S, Cantwell LB, Farlow MR, Grafman J, Huey ED, Ryung Han M, Beecher S, Geller ET, Kretzschmar HA, Roeber S, Gearing M, Juncos JL, Vonsattel JP, Van Deerlin VM, Grossman M, Hurtig HI, Gross RG, Arnold SE, Trojanowski JQ, Lee VM, Wenning GK, White CL, Höglinger GU, Müller U, Devlin B, Golbe LI, Crook J, Parisi JE, Boeve BF, Josephs KA, Wszolek ZK, Uitti RJ, Graff-Radford NR, Litvan I, Younkin SG, Wang LS, Ertekin-Taner N, Rademakers R, Hakonarsen H, Schellenberg GD, Dickson DW. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat Commun. 2015 Jun 16; 6:7247. PMID: 26077951; PMCID: PMC4469997.
    52. Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. Mov Disord. 2015 Jun; 30(7):919-27. PMID: 25737166; PMCID: PMC4855523.
    53. Pirogovsky-Turk E, Filoteo JV, Litvan I, Harrington DL. Structural MRI Correlates of Episodic Memory Processes in Parkinson's Disease Without Mild Cognitive Impairment. J Parkinsons Dis. 2015; 5(4):971-81. PMID: 26577652.
      View in: PubMed
    54. Grijalvo-Perez AM, Litvan I. Corticobasal degeneration. Semin Neurol. 2014 Apr; 34(2):160-73. PMID: 24963675.
      View in: PubMed
    55. Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, Roberson ED, Höglinger GU, Koestler M, Jack CR, Van Deerlin V, Randolph C, Lobach IV, Heuer HW, Gozes I, Parker L, Whitaker S, Hirman J, Stewart AJ, Gold M, Morimoto BH. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurol. 2014 Jul; 13(7):676-85. PMID: 24873720; PMCID: PMC4129545.
    56. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014 May; 71(5):543-52. PMID: 24664227.
      View in: PubMed
    57. Burn D, Weintraub D, Ravina B, Litvan I. Cognition in movement disorders: where can we hope to be in ten years? Mov Disord. 2014 Apr 15; 29(5):704-11. PMID: 24757118; PMCID: PMC4371593.
    58. Pirogovsky E, Schiehser DM, Litvan I, Obtera KM, Burke MM, Lessig SL, Song DD, Liu L, Filoteo JV. The utility of the Mattis Dementia Rating Scale in Parkinson's disease mild cognitive impairment. Parkinsonism Relat Disord. 2014 Jun; 20(6):627-31. PMID: 24709086.
      View in: PubMed
    59. Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord. 2014 Apr; 29(4):454-62. PMID: 24619848.
      View in: PubMed
    60. Litvan I, Kong M. Rate of decline in progressive supranuclear palsy. Mov Disord. 2014 Apr; 29(4):463-8. PMID: 24615741.
      View in: PubMed
    61. Tolosa E, Litvan I, Höglinger GU, Burn D, Lees A, Andrés MV, Gómez-Carrillo B, León T, Del Ser T. A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy. Mov Disord. 2014 Apr; 29(4):470-8. PMID: 24532007.
      View in: PubMed
    62. Monsell SE, Besser LM, Heller KB, Checkoway H, Litvan I, Kukull WA. Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status. Parkinsonism Relat Disord. 2014 May; 20(5):503-7. PMID: 24582705; PMCID: PMC4028373.
    63. Pirogovsky E, Schiehser DM, Obtera KM, Burke MM, Lessig SL, Song DD, Litvan I, Filoteo JV. Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment. Neuropsychology. 2014 Mar; 28(2):229-37. PMID: 24417192.
      View in: PubMed
    64. Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I. Parkinson's disease mild cognitive impairment: application and validation of the criteria. J Parkinsons Dis. 2014; 4(2):131-7. PMID: 24296865; PMCID: PMC4380013.
    65. Gatto E, Rodríguez-Violante M, Cosentino C, Chana-Cuevas P, Miranda M, Gallin E, Etcheverry JL, Nuñez Y, Parisi V, Persi G, Vecchi C, Sanguinetti A, Alleva A, Aparcana J, Torres L, Litvan I. Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophy. J Parkinsons Dis. 2014; 4(4):693-8. PMID: 25213997.
      View in: PubMed
    66. Duff K, Shprecher D, Litvan I, Gerstenecker A, Mast B. Correcting for demographic variables on the modified telephone interview for cognitive status. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1438-43. PMID: 24125814; PMCID: PMC3984368.
    67. Williams DR, Litvan I. Parkinsonian syndromes. Continuum (Minneap Minn). 2013 Oct; 19(5 Movement Disorders):1189-212. PMID: 24092286; PMCID: PMC4234134.
    68. Pirogovsky E, Martinez-Hannon M, Schiehser DM, Lessig SL, Song DD, Litvan I, Filoteo JV. Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson's disease. J Clin Exp Neuropsychol. 2013; 35(9):926-33. PMID: 24074137.
      View in: PubMed
    69. Gerstenecker A, Duff K, Mast B, Litvan I. Behavioral abnormalities in progressive supranuclear palsy. Psychiatry Res. 2013 Dec 30; 210(3):1205-10. PMID: 24035530; PMCID: PMC3840159.
    70. Filoteo JV, Reed JD, Litvan I, Harrington DL. Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease. Mov Disord. 2014 Mar; 29(3):360-7. PMID: 24038502; PMCID: PMC4758346.
    71. Thompson MR, Stone RF, Dan Ochs V, Litvan I. Primary health care providers' knowledge gaps on Parkinson's disease. Educ Gerontol. 2013; 39(11):856-862. PMID: 28133411.
      View in: PubMed
    72. Reginold W, Duff-Canning S, Meaney C, Armstrong MJ, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Marshall F, Mapstone M, Chou KL, Persad C, Litvan I, Mast B, Tang-Wai D, Lang AE, Marras C. Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease. Dement Geriatr Cogn Disord. 2013; 36(1-2):67-75. PMID: 23774742.
      View in: PubMed
    73. Theilmann RJ, Reed JD, Song DD, Huang MX, Lee RR, Litvan I, Harrington DL. White-matter changes correlate with cognitive functioning in Parkinson's disease. Front Neurol. 2013; 4:37. PMID: 23630517; PMCID: PMC3624087.
    74. Marras C, Armstrong MJ, Meaney CA, Fox S, Rothberg B, Reginold W, Tang-Wai DF, Gill D, Eslinger PJ, Zadikoff C, Kennedy N, Marshall FJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Gerstenecker AT, Weintraub S, Duff-Canning S. Measuring mild cognitive impairment in patients with Parkinson's disease. Mov Disord. 2013 May; 28(5):626-33. PMID: 23520128; PMCID: PMC4524474.
    75. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Tröster AI, Vidailhet M, Weiner WJ. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013 Jan 29; 80(5):496-503. PMID: 23359374; PMCID: PMC3590050.
    76. Duff K, Gerstenecker A, Litvan I. Functional impairment in progressive supranuclear palsy. Neurology. 2013 Jan 22; 80(4):380-4. PMID: 23303854; PMCID: PMC3589239.
    77. Sauvaget F, Litvan I. Toward magnetic resonance imaging biomarkers for progressive supranuclear palsy and multisystem atrophy. Mov Disord. 2012 Dec; 27(14):1711-3. PMID: 23283652.
      View in: PubMed
    78. Gerstenecker A, Mast B, Duff K, Ferman TJ, Litvan I. Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol. 2013 Mar; 28(2):104-13. PMID: 23127882; PMCID: PMC3569947.
    79. Armstrong MJ, Duff-Canning S, Tang-Wai DF, Fox S, Zadikoff C, Kennedy N, Gill D, Eslinger PJ, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Marras C. The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease. Parkinsonism Relat Disord. 2013 Apr; 19(4):463-5. PMID: 23036511.
      View in: PubMed
    80. Armstrong MJ, Naglie G, Duff-Canning S, Meaney C, Gill D, Eslinger PJ, Zadikoff C, Mapstone M, Chou KL, Persad C, Litvan I, Mast BT, Fox S, Tang-Wai DF, Marras C. Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra. 2012 Jan; 2(1):343-52. PMID: 22962558; PMCID: PMC3435526.
    81. Reginold W, Armstrong MJ, Duff-Canning S, Lang A, Tang-Wai D, Fox S, Rothberg B, Zadikoff C, Kennedy N, Gill D, Eslinger P, Mapstone M, Chou K, Persad C, Litvan I, Mast B, Marras C. The pill questionnaire in a nondemented Parkinson's disease population. Mov Disord. 2012 Sep 01; 27(10):1308-11. PMID: 22865587.
      View in: PubMed
    82. Munhoz RP, Espay AJ, Morgante F, Li JY, Teive HA, Dunn E, Gallin E, Litvan I. Long-duration Parkinson's disease: role of lateralization of motor features. Parkinsonism Relat Disord. 2013 Jan; 19(1):77-80. PMID: 22858180; PMCID: PMC3635808.
    83. Simões RM, Constantino A, Gibadullina E, Houghton D, Louis ED, Litvan I. Examining the motor phenotype of patients with both essential tremor and Parkinson's disease. Tremor Other Hyperkinet Mov (N Y). 2012; 2. PMID: 23439850; PMCID: PMC3379814.
    84. Potts LF, Cambon AC, Ross OA, Rademakers R, Dickson DW, Uitti RJ, Wszolek ZK, Rai SN, Farrer MJ, Hein DW, Litvan I. Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study. BMC Med Genet. 2012 Mar 17; 13:16. PMID: 22424094; PMCID: PMC3344705.
    85. Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J. Phosphorylated a-synuclein in Parkinson's disease. Sci Transl Med. 2012 Feb 15; 4(121):121ra20. PMID: 22344688; PMCID: PMC3302662.
    86. Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012 Mar; 27(3):349-56. PMID: 22275317; PMCID: PMC3641655.
    87. Goldman JG, Litvan I. Mild cognitive impairment in Parkinson's disease. Minerva Med. 2011 Dec; 102(6):441-59. PMID: 22193376; PMCID: PMC3370887.
    88. Potts LF, Luzzio FA, Smith SC, Hetman M, Champy P, Litvan I. Annonacin in Asimina triloba fruit: implication for neurotoxicity. Neurotoxicology. 2012 Jan; 33(1):53-8. PMID: 22130466.
      View in: PubMed
    89. Kouri N, Murray ME, Hassan A, Rademakers R, Uitti RJ, Boeve BF, Graff-Radford NR, Wszolek ZK, Litvan I, Josephs KA, Dickson DW. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain. 2011 Nov; 134(Pt 11):3264-75. PMID: 21933807; PMCID: PMC3212714.
    90. Espay AJ, Litvan I. Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci. 2011 Nov; 45(3):343-9. PMID: 21892619; PMCID: PMC3324113.
    91. Ferrara JM, Adam OR, Kirwin SM, Houghton DJ, Shepherd C, Vinette KM, Litvan I. Brain-lung-thyroid disease: clinical features of a kindred with a novel thyroid transcription factor 1 mutation. J Child Neurol. 2012 Jan; 27(1):68-73. PMID: 21813802.
      View in: PubMed
    92. Fernández-Botrán R, Ahmed Z, Crespo FA, Gatenbee C, Gonzalez J, Dickson DW, Litvan I. Cytokine expression and microglial activation in progressive supranuclear palsy. Parkinsonism Relat Disord. 2011 Nov; 17(9):683-8. PMID: 21741294; PMCID: PMC3196843.
    93. Höglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE, van Swieten JC, Heutink P, Wszolek ZK, Uitti RJ, Vandrovcova J, Hurtig HI, Gross RG, Maetzler W, Goldwurm S, Tolosa E, Borroni B, Pastor P. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet. 2011 Jun 19; 43(7):699-705. PMID: 21685912.
      View in: PubMed
    94. Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Tröster AI, Weintraub D. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord. 2011 Aug 15; 26(10):1814-24. PMID: 21661055; PMCID: PMC3181006.
    95. Silverberg NB, Ryan LM, Carrillo MC, Sperling R, Petersen RC, Posner HB, Snyder PJ, Hilsabeck R, Gallagher M, Raber J, Rizzo A, Possin K, King J, Kaye J, Ott BR, Albert MS, Wagster MV, Schinka JA, Cullum CM, Farias ST, Balota D, Rao S, Loewenstein D, Budson AE, Brandt J, Manly JJ, Barnes L, Strutt A, Gollan TH, Ganguli M, Babcock D, Litvan I, Kramer JH, Ferman TJ. Assessment of cognition in early dementia. Alzheimers Dement. 2011 May 01; 7(3):e60-e76. PMID: 23559893.
      View in: PubMed
    96. Wenning GK, Litvan I, Tolosa E. Milestones in atypical and secondary Parkinsonisms. Mov Disord. 2011 May; 26(6):1083-95. PMID: 21626553.
      View in: PubMed
    97. Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY. A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Mov Disord. 2010 Nov 15; 25(15):2501-7. PMID: 20878991; PMCID: PMC2978783.
    98. Bickel S, Alvarez L, Macias R, Pavon N, Leon M, Fernandez C, Houghton DJ, Salazar S, Rodríguez-Oroz MC, Juncos J, Guridi J, Delong M, Obeso JA, Litvan I. Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease. Parkinsonism Relat Disord. 2010 Sep; 16(8):535-9. PMID: 20650671.
      View in: PubMed
    99. Espay AJ, Spina S, Houghton DJ, Murrell JR, de Courten-Myers GM, Ghetti B, Litvan I. Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease. J Neurol Neurosurg Psychiatry. 2011 Jul; 82(7):751-3. PMID: 20587488; PMCID: PMC4449730.
    100. Schrag A, Sheikh S, Quinn NP, Lees AJ, Selai C, Mathias C, Litvan I, Lang AE, Bower JH, Burn DJ, Low P, Jahanshahi M. A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Mov Disord. 2010 Jun 15; 25(8):1077-81. PMID: 20535826.
      View in: PubMed
    101. Litvan I, Chism A, Litvan J, Cambon A, Hutton M. H1/H1 genotype influences symptom severity in corticobasal syndrome. Mov Disord. 2010 Apr 30; 25(6):760-3. PMID: 20437541.
      View in: PubMed
    102. Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol. 2009 Dec; 8(12):1128-39. PMID: 19909911.
      View in: PubMed
    103. Dickson DW, Braak H, Duda JE, Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZK, Litvan I. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 2009 Dec; 8(12):1150-7. PMID: 19909913.
      View in: PubMed
    104. Uc EY, McDermott MP, Marder KS, Anderson SW, Litvan I, Como PG, Auinger P, Chou KL, Growdon JC. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology. 2009 Nov 03; 73(18):1469-77. PMID: 19884574; PMCID: PMC2779004.
    105. Ludolph AC, Kassubek J, Landwehrmeyer BG, Mandelkow E, Mandelkow EM, Burn DJ, Caparros-Lefebvre D, Frey KA, de Yebenes JG, Gasser T, Heutink P, Höglinger G, Jamrozik Z, Jellinger KA, Kazantsev A, Kretzschmar H, Lang AE, Litvan I, Lucas JJ, McGeer PL, Melquist S, Oertel W, Otto M, Paviour D, Reum T, Saint-Raymond A, Steele JC, Tolnay M, Tumani H, van Swieten JC, Vanier MT, Vonsattel JP, Wagner S, Wszolek ZK. Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol. 2009 Mar; 16(3):297-309. PMID: 19364361; PMCID: PMC2847416.
    106. Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Goldwurm S, Pezzoli G, Zini M, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Laramie JM, DeStefano AL, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med. 2008 Nov 05; 6:32. PMID: 18986508; PMCID: PMC2596771.
    107. McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Saint-Hilaire MH, Massood T, Huskey KW, DeStefano AL, Gillis T, Mysore J, Goldwurm S, Pezzoli G, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord. 2008 Aug 15; 23(11):1596-601. PMID: 18649400; PMCID: PMC2655323.
    108. DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, Singer C, Goldwurm S, Pezzoli G, Saint-Hilaire MH, Hendricks AE, Gower A, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Hum Genet. 2008 Aug; 124(1):95-9. PMID: 18587682; PMCID: PMC2716559.
    109. Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, Goldwurm S, Pezzoli G, Singer C, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Laramie JM, DeStefano AL, Litvan I, Nicholson G, Corbett A, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Sherman S, Al-hinti J, Drasby E, Nance M, Moller AT, Ostergaard K, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 2008 Jul 01; 71(1):28-34. PMID: 18509094; PMCID: PMC2654275.
    110. van Balken I, Litvan I. Current and future therapeutic approaches in progressive supranuclear palsy. Handb Clin Neurol. 2008; 89:493-508. PMID: 18631772.
      View in: PubMed
    111. Duyckaerts C, Litvan I. "Softening of the brain." Preface. Handb Clin Neurol. 2008; 89:ix. PMID: 18631725.
      View in: PubMed
    112. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007 Dec; 22(16):2314-24. PMID: 18098298.
      View in: PubMed
    113. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007 Sep 15; 22(12):1689-707; quiz 1837. PMID: 17542011.
      View in: PubMed
    114. Litvan I. Update of atypical Parkinsonian disorders. Curr Opin Neurol. 2007 Aug; 20(4):434-7. PMID: 17620879.
      View in: PubMed
    115. Litvan I, Chesselet MF, Gasser T, Di Monte DA, Parker D, Hagg T, Hardy J, Jenner P, Myers RH, Price D, Hallett M, Langston WJ, Lang AE, Halliday G, Rocca W, Duyckaerts C, Dickson DW, Ben-Shlomo Y, Goetz CG, Melamed E. The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. J Neuropathol Exp Neurol. 2007 May; 66(5):329-36. PMID: 17483689.
      View in: PubMed
    116. Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, Langston WJ, Di Monte DA, Gasser T, Hagg T, Hardy J, Jenner P, Melamed E, Myers RH, Parker D, Price DL. The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol. 2007 Apr; 66(4):251-7. PMID: 17413315.
      View in: PubMed
    117. Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, Tuite P, Calne DB, Bigio EH, Uitti RJ, Wszolek ZK, Golbe LI, Caselli RJ, Graff-Radford N, Litvan I, Farrer MJ, Dickson DW, Hutton M, Stephan DA. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet. 2007 Apr; 80(4):769-78. PMID: 17357082; PMCID: PMC1852701.
    118. Houghton DJ, Litvan I. Unraveling progressive supranuclear palsy: from the bedside back to the bench. Parkinsonism Relat Disord. 2007; 13 Suppl 3:S341-6. PMID: 18267262.
      View in: PubMed
    119. Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Berg CJ, Sun M, Goldwurm S, Pezzoli G, Racette BA, Perlmutter JS, Parsian A, Baker KB, Giroux ML, Litvan I, Pramstaller PP, Nicholson G, Burn DJ, Chinnery PF, Vieregge P, Slevin JT, Cambi F, MacDonald ME, Gusella JF, Myers RH, Golbe LI. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 2006 Dec 26; 67(12):2206-10. PMID: 17190945.
      View in: PubMed
    120. Chand P, Grafman J, Dickson D, Ishizawa K, Litvan I. Alzheimer's disease presenting as corticobasal syndrome. Mov Disord. 2006 Nov; 21(11):2018-22. PMID: 16977625.
      View in: PubMed
    121. Schrag A, Selai C, Quinn N, Lees A, Litvan I, Lang A, Poon Y, Bower J, Burn D, Hobart J. Measuring quality of life in PSP: the PSP-QoL. Neurology. 2006 Jul 11; 67(1):39-44. PMID: 16832075.
      View in: PubMed
    122. Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Suchowersky O, Labelle N, Growdon JH, Singer C, Watts RL, Goldwurm S, Pezzoli G, Baker KB, Pramstaller PP, Burn DJ, Chinnery PF, Sherman S, Vieregge P, Litvan I, Gillis T, MacDonald ME, Myers RH, Gusella JF. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol. 2006 Jun; 63(6):826-32. PMID: 16769863.
      View in: PubMed
    123. van Balken I, Litvan I. Current and future treatments in progressive supranuclear palsy. Curr Treat Options Neurol. 2006 May; 8(3):211-23. PMID: 16569380.
      View in: PubMed
    124. Gröschel K, Kastrup A, Litvan I, Schulz JB. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology. 2006 Mar 28; 66(6):949-50. PMID: 16567726.
      View in: PubMed
    125. Ross OA, Toft M, Whittle AJ, Johnson JL, Papapetropoulos S, Mash DC, Litvan I, Gordon MF, Wszolek ZK, Farrer MJ, Dickson DW. Lrrk2 and Lewy body disease. Ann Neurol. 2006 Feb; 59(2):388-93. PMID: 16437559.
      View in: PubMed
    126. Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, Prakash R, Tobin S, Williamson J, Suchowersky O, Labell N, Growdon BN, Singer C, Watts R, Goldwurm S, Pezzoli G, Baker KB, Giroux ML, Pramstaller PP, Burn DJ, Chinnery P, Sherman S, Vieregge P, Litvan I, Gusella JF, Myers RH, Parsian A. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 2005 Dec 13; 65(11):1823-5. PMID: 16344533.
      View in: PubMed
    127. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005 Dec 27; 65(12):1863-72. PMID: 16237129.
      View in: PubMed
    128. Rademakers R, Melquist S, Cruts M, Theuns J, Del-Favero J, Poorkaj P, Baker M, Sleegers K, Crook R, De Pooter T, Bel Kacem S, Adamson J, Van den Bossche D, Van den Broeck M, Gass J, Corsmit E, De Rijk P, Thomas N, Engelborghs S, Heckman M, Litvan I, Crook J, De Deyn PP, Dickson D, Schellenberg GD, Van Broeckhoven C, Hutton ML. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet. 2005 Nov 01; 14(21):3281-92. PMID: 16195395.
      View in: PubMed
    129. Tsuboi Y, Josephs KA, Boeve BF, Litvan I, Caselli RJ, Caviness JN, Uitti RJ, Bott AD, Dickson DW. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord. 2005 Aug; 20(8):982-8. PMID: 15834857.
      View in: PubMed
    130. Magherini A, Litvan I. Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski's description of PSP 40 years ago and Albert's delineation of the subcortical dementia 30 years ago. Neurocase. 2005 Aug; 11(4):250-62. PMID: 16093225.
      View in: PubMed
    131. Dubois B, Slachevsky A, Pillon B, Beato R, Villalponda JM, Litvan I. "Applause sign" helps to discriminate PSP from FTD and PD. Neurology. 2005 Jun 28; 64(12):2132-3. PMID: 15985587.
      View in: PubMed
    132. Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, Juncos JL, Maragoto C, Guridi J, Litvan I, Tolosa ES, Koller W, Vitek J, DeLong MR, Obeso JA. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain. 2005 Mar; 128(Pt 3):570-83. PMID: 15689366.
      View in: PubMed
    133. Litvan I. Update on progressive supranuclear palsy. Curr Neurol Neurosci Rep. 2004 Jul; 4(4):296-302. PMID: 15217544.
      View in: PubMed
    134. Gröschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, Schulz JB. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage. 2004 Feb; 21(2):714-24. PMID: 14980574.
      View in: PubMed
    135. Litvan I. Update on epidemiological aspects of progressive supranuclear palsy. Mov Disord. 2003 Sep; 18 Suppl 6:S43-50. PMID: 14502655.
      View in: PubMed
    136. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003 Sep; 74(9):1215-20. PMID: 12933921; PMCID: PMC1738667.
    137. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KD, Shults C, Wenning GK. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003 May; 18(5):467-86. PMID: 12722160.
      View in: PubMed
    138. Goetz CG, Leurgans S, Lang AE, Litvan I. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology. 2003 Mar 25; 60(6):917-22. PMID: 12654953.
      View in: PubMed
    139. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003; 54 Suppl 5:S15-9. PMID: 12833363.
      View in: PubMed
    140. Frattali C, Duffy JR, Litvan I, Patsalides AD, Grafman J. Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control? Eur J Neurol. 2003 Jan; 10(1):103-6. PMID: 12535005.
      View in: PubMed
    141. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002 Nov; 61(11):935-46. PMID: 12430710.
      View in: PubMed
    142. Müller J, Seppi K, Stefanova N, Poewe W, Litvan I, Wenning GK. Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov Disord. 2002 Sep; 17(5):1041-5. PMID: 12360556.
      View in: PubMed
    143. Jellinger KA, Paulus W, Wrocklage C, Litvan I. Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. BMC Neurol. 2001 Dec 18; 1:3. PMID: 11504565; PMCID: PMC37390.
    144. Jellinger KA, Paulus W, Wrocklage C, Litvan I. Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. Eur J Neurol. 2001 Nov; 8(6):707-10. PMID: 11784357.
      View in: PubMed
    145. Kulisevsky J, Litvan I, Berthier ML, Pascual-Sedano B, Paulsen JS, Cummings JL. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders. Mov Disord. 2001 Nov; 16(6):1098-104. PMID: 11748741.
      View in: PubMed
    146. Litvan I, Phipps M, Pharr VL, Hallett M, Grafman J, Salazar A. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology. 2001 Aug 14; 57(3):467-73. PMID: 11502915.
      View in: PubMed
    147. Litvan I, Baker M, Hutton M. Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy. Neurology. 2001 Jul 10; 57(1):138-40. PMID: 11445645.
      View in: PubMed
    148. Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 2001 Jun 26; 56(12):1702-6. PMID: 11425937.
      View in: PubMed
    149. Litvan I. Therapy and management of frontal lobe dementia patients. Neurology. 2001 Jun; 56(11 Suppl 4):S41-5. PMID: 11402150.
      View in: PubMed
    150. Pharr V, Uttl B, Stark M, Litvan I, Fantie B, Grafman J. Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology. 2001 Apr 10; 56(7):957-63. PMID: 11294936.
      View in: PubMed
    151. Sommer M, Grafman J, Litvan I, Hallett M. Impairment of eyeblink classical conditioning in progressive supranuclear palsy. Mov Disord. 2001 Mar; 16(2):240-51. PMID: 11295776.
      View in: PubMed
    152. Müller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol. 2001 Feb; 58(2):259-64. PMID: 11176964.
      View in: PubMed
    153. Litvan I. Diagnosis and management of progressive supranuclear palsy. Semin Neurol. 2001; 21(1):41-8. PMID: 11346024.
      View in: PubMed
    154. Aarsland D, Litvan I, Larsen JP. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2001; 13(1):42-9. PMID: 11207328.
      View in: PubMed
    155. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000 Dec 12; 55(11):1621-6. PMID: 11113214.
      View in: PubMed
    156. Swerdlow RH, Golbe LI, Parks JK, Cassarino DS, Binder DR, Grawey AE, Litvan I, Bennett JP, Wooten GF, Parker WD. Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J Neurochem. 2000 Oct; 75(4):1681-4. PMID: 10987850.
      View in: PubMed
    157. Müller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I. Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology. 2000 Sep 26; 55(6):888-91. PMID: 10994019.
      View in: PubMed
    158. Hallet M, Litvan I. Scientific position paper of the Movement Disorder Society evaluation of surgery for Parkinson's disease. Mov Disord. 2000 May; 15(3):436-438. PMID: 28470731.
      View in: PubMed
    159. Litvan I, Dickson DW, Buttner-Ennever JA, Delacourte A, Hutton M, Dubois B, Golbe LI, Hallett M, Schellenberg GD, Standaert D, Brooks DJ, Price D. Research goals in progressive supranuclear palsy. Mov Disord. 2000 May; 15(3):446-458. PMID: 28470736.
      View in: PubMed
    160. Litvan I, Dickson DW, Buttner-Ennever JA, Delacourte A, Hutton M, Dubois B, Golbe LI, Hallett M, Schellenberg GD, Standaert D, Brooks DJ, Price D. Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP. Mov Disord. 2000 May; 15(3):446-58. PMID: 10830408.
      View in: PubMed
    161. Hallett M, Litvan I. Scientific position paper of the Movement Disorder Society evaluation of surgery for Parkinson's disease. Task Force on Surgery for Parkinson's Disease of the American Academy of Neurology Therapeutic and Technology Assessment Committee. Mov Disord. 2000 May; 15(3):436-8. PMID: 10830406.
      View in: PubMed
    162. Rivaud-Péchoux S, Vidailhet M, Gallouedec G, Litvan I, Gaymard B, Pierrot-Deseilligny C. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology. 2000 Mar 14; 54(5):1029-32. PMID: 10720270.
      View in: PubMed
    163. Frattali CM, Grafman J, Patronas N, Makhlouf F, Litvan I. Language disturbances in corticobasal degeneration. Neurology. 2000 Feb 22; 54(4):990-2. PMID: 10691002.
      View in: PubMed
    164. Litvan I, Grimes DA, Lang AE. Phenotypes and prognosis: clinicopathologic studies of corticobasal degeneration. Adv Neurol. 2000; 82:183-96. PMID: 10624482.
      View in: PubMed
    165. Cummings JL, Litvan I. Neuropsychiatric aspects of corticobasal degeneration. Adv Neurol. 2000; 82:147-52. PMID: 10624478.
      View in: PubMed
    166. Hallett M, Litvan I. Evaluation of surgery for Parkinson's disease: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. The Task Force on Surgery for Parkinson's Disease. Neurology. 1999 Dec 10; 53(9):1910-21. PMID: 10599758.
      View in: PubMed
    167. Grafman J, Litvan I. Importance of deficits in executive functions. Lancet. 1999 Dec 04; 354(9194):1921-3. PMID: 10622291.
      View in: PubMed
    168. Wenning GK, Scherfler C, Granata R, Bösch S, Verny M, Chaudhuri KR, Jellinger K, Poewe W, Litvan I. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1999 Nov; 67(5):620-3. PMID: 10519868; PMCID: PMC1736638.
    169. Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, Litvan I. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord. 1999 Nov; 14(6):947-50. PMID: 10584668.
      View in: PubMed
    170. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G. [Consensus on the diagnosis of multi-system atrophy]. Neurologia. 1999 Nov; 14(9):425-8. PMID: 10613015.
      View in: PubMed
    171. Lopez OL, Litvan I, Catt KE, Stowe R, Klunk W, Kaufer DI, Becker JT, DeKosky ST. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology. 1999 Oct 12; 53(6):1292-9. PMID: 10522887.
      View in: PubMed
    172. Litvan I, Grimes DA, Lang AE, Jankovic J, McKee A, Verny M, Jellinger K, Chaudhuri KR, Pearce RK. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol. 1999 Sep; 246 Suppl 2:II1-5. PMID: 10525996.
      View in: PubMed
    173. Litvan I. Recent advances in atypical parkinsonian disorders. Curr Opin Neurol. 1999 Aug; 12(4):441-6. PMID: 10555833.
      View in: PubMed
    174. Litvan I. [Recent advances in Parkinson disease]. Rev Neurol. 1999 Jul 16-31; 29(2):139-45. PMID: 10528328.
      View in: PubMed
    175. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet. 1999 Apr; 8(4):711-5. PMID: 10072441.
      View in: PubMed
    176. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999 Feb 01; 163(1):94-8. PMID: 10223419.
      View in: PubMed
    177. Higgins JJ, Litvan I, Nee LE, Loveless JM. A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration. Neurology. 1999 Jan 15; 52(2):404-6. PMID: 9932968.
      View in: PubMed
    178. Litvan I, Lees AJ. Progressive supranuclear palsy. Adv Neurol. 1999; 80:341-5. PMID: 10410739.
      View in: PubMed
    179. Frattali CM, Sonies BC, Chi-Fishman G, Litvan I. Effects of physostigmine on swallowing and oral motor functions in patients with progressive supranuclear palsy: A pilot study. Dysphagia. 1999; 14(3):165-8. PMID: 10341115.
      View in: PubMed
    180. Pharr V, Litvan I, Brat DJ, Troncoso J, Reich SG, Stark M. Ideomotor apraxia in progressive supranuclear palsy: a case study. Mov Disord. 1999 Jan; 14(1):162-6. PMID: 9918365.
      View in: PubMed
    181. Litvan I, McKee A. Clinicopathologic case report. Dementia with Lewy bodies (DLB). J Neuropsychiatry Clin Neurosci. 1999; 11(1):107-12. PMID: 9990566.
      View in: PubMed
    182. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK. Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst. 1998 Dec 11; 74(2-3):189-92. PMID: 9915636.
      View in: PubMed
    183. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, Lantos P, Litvan I, Mathias C, Oliver E, Robertson D, Schatz I, Wenning G. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res. 1998 Dec; 8(6):359-62. PMID: 9869555.
      View in: PubMed
    184. Litvan I. Progressive supranuclear palsy revisited. Acta Neurol Scand. 1998 Dec; 98(6):73-84. PMID: 9875630.
      View in: PubMed
    185. Litvan I, Cummings JL, Mega M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry. 1998 Nov; 65(5):717-21. PMID: 9810944; PMCID: PMC2170337.
    186. Uttl B, Santacruz P, Litvan I, Grafman J. Caregiving in progressive supranuclear palsy. Neurology. 1998 Nov; 51(5):1303-9. PMID: 9818850.
      View in: PubMed
    187. Litvan I, Paulsen JS, Mega MS, Cummings JL. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Arch Neurol. 1998 Oct; 55(10):1313-9. PMID: 9779658.
      View in: PubMed
    188. Kompoliti K, Goetz CG, Litvan I, Jellinger K, Verny M. Pharmacological therapy in progressive supranuclear palsy. Arch Neurol. 1998 Aug; 55(8):1099-102. PMID: 9708960.
      View in: PubMed
    189. Wenning GK, Litvan I, Verny M, Ray-Chaudhuri K, Granata R, Poewe W, Jellinger K. Is EEG useful in the differential diagnosis of parkinsonism? Parkinsonism Relat Disord. 1998 Aug; 4(2):79-80. PMID: 18591093.
      View in: PubMed
    190. Litvan I. Progressive supranuclear palsy revisited. Acta Neurol Scand. 1998 Aug; 98(2):73-84. PMID: 9724003.
      View in: PubMed
    191. Fine EJ, Hallett M, Litvan I, Tresser N, Katz D. Dysfunction of Ib (autogenic) spinal inhibition in patients with progressive supranuclear palsy. Mov Disord. 1998 Jul; 13(4):668-72. PMID: 9686772.
      View in: PubMed
    192. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, Bartko JJ, Jankovic J, McKee A, Brandel JP, Chaudhuri KR, Lai EC, D'Olhaberriague L, Pearce RK, Agid Y. Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol. 1998 Jul; 55(7):969-78. PMID: 9678315.
      View in: PubMed
    193. Santacruz P, Uttl B, Litvan I, Grafman J. Progressive supranuclear palsy: a survey of the disease course. Neurology. 1998 Jun; 50(6):1637-47. PMID: 9633705.
      View in: PubMed
    194. Litvan I, Saunders AM. Apolipoprotein E4 (epsilon) allele does not affect the onset or symptom severity in progressive supranuclear palsy. Arch Neurol. 1998 May; 55(5):752-4. PMID: 9605738.
      View in: PubMed
    195. Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, Poewe W, Jellinger K, Ray Chaudhuri K, D'Olhaberriague L, Pearce RK. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 1998 Feb; 64(2):184-9. PMID: 9489528; PMCID: PMC2169933.
    196. Litvan I, Hutton M. Clinical and genetic aspects of progressive supranuclear palsy. J Geriatr Psychiatry Neurol. 1998; 11(2):107-14. PMID: 9877531.
      View in: PubMed
    197. Higgins JJ, Litvan I, Pho LT, Li W, Nee LE. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurology. 1998 Jan; 50(1):270-3. PMID: 9443491.
      View in: PubMed
    198. Litvan I, Booth V, Wenning GK, Bartko JJ, Goetz CG, McKee A, Jankovic J, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm (Vienna). 1998; 105(2-3):217-27. PMID: 9660099.
      View in: PubMed
    199. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I. Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998; 10(3):314-9. PMID: 9706539.
      View in: PubMed
    200. Litvan I. [Parkinsonian syndromes and Parkinson's disease: differential clinical diagnosis]. Neurologia. 1998; 13 Suppl 1:30-5. PMID: 9859683.
      View in: PubMed
    201. Tedeschi G, Litvan I, Bonavita S, Bertolino A, Lundbom N, Patronas NJ, Hallett M. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain. 1997 Sep; 120 ( Pt 9):1541-52. PMID: 9313638.
      View in: PubMed
    202. Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, McKee A, Jellinger K, Lai EC, Brandel JP, Verny M, Chaudhuri KR, Pearce RK, Agid Y. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol. 1997 Aug; 54(8):937-44. PMID: 9267967.
      View in: PubMed
    203. Litvan I. The clinical and pathologic hallmarks of progressive supranuclear palsy. Curr Opin Neurol. 1997 Aug; 10(4):346-50. PMID: 9266160.
      View in: PubMed
    204. Litvan I, Agid Y, Sastry N, Jankovic J, Wenning GK, Goetz CG, Verny M, Brandel JP, Jellinger K, Chaudhuri KR, McKee A, Lai EC, Pearce RK, Bartko JJ, Sastrj N. What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology. 1997 Jul; 49(1):62-9. PMID: 9222171.
      View in: PubMed
    205. Litvan I, Sastry N, Sonies BC. Characterizing swallowing abnormalities in progressive supranuclear palsy. Neurology. 1997 Jun; 48(6):1654-62. PMID: 9191782.
      View in: PubMed
    206. Litvan I. Progressive supranuclear palsy and corticobasal degeneration. Baillieres Clin Neurol. 1997 Apr; 6(1):167-85. PMID: 9426874.
      View in: PubMed
    207. Litvan I, Agid Y, Goetz C, Jankovic J, Wenning GK, Brandel JP, Lai EC, Verny M, Ray-Chaudhuri K, McKee A, Jellinger K, Pearce RK, Bartko JJ. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 1997 Jan; 48(1):119-25. PMID: 9008506.
      View in: PubMed
    208. Wenning GK, Jellinger K, Litvan I. Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neural Transm (Vienna). 1997; 104(8-9):845-65. PMID: 9451717.
      View in: PubMed
    209. Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RK, D'Olhaberriague L. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study. Brain. 1997 Jan; 120 ( Pt 1):65-74. PMID: 9055798.
      View in: PubMed
    210. Litvan I, Mega MS, Cummings JL, Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology. 1996 Nov; 47(5):1184-9. PMID: 8909427.
      View in: PubMed
    211. Litvan I, FitzGibbon EJ. Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects? Neurology. 1996 Nov; 47(5):1324-6. PMID: 8909451.
      View in: PubMed
    212. Litvan I, Mangone CA, Werden W, Bueri JA, Estol CJ, Garcea DO, Rey RC, Sica RE, Hallett M, Bartko JJ. Reliability of the NINDS Myotatic Reflex Scale. Neurology. 1996 Oct; 47(4):969-72. PMID: 8857728.
      View in: PubMed
    213. Dimitrov M, Grafman J, Kosseff P, Wachs J, Alway D, Higgins J, Litvan I, Lou JS, Hallett M. Preserved cognitive processes in cerebellar degeneration. Behav Brain Res. 1996 Sep; 79(1-2):131-5. PMID: 8883824.
      View in: PubMed
    214. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996 Jul; 47(1):1-9. PMID: 8710059.
      View in: PubMed
    215. Litvan I, DeLeo JM, Hauw JJ, Daniel SE, Jellinger K, McKee A, Dickson D, Horoupian DS, Lantos PL, Tabaton M. What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? Brain. 1996 Jun; 119 ( Pt 3):831-9. PMID: 8673495.
      View in: PubMed
    216. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, D'Olhaberriague L, Chaudhuri KR, Pearce RK. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1996 Jun; 60(6):615-20. PMID: 8648326; PMCID: PMC1073943.
    217. Rueckert L, Lange N, Partiot A, Appollonio I, Litvan I, Le Bihan D, Grafman J. Visualizing cortical activation during mental calculation with functional MRI. Neuroimage. 1996 Apr; 3(2):97-103. PMID: 9345480.
      View in: PubMed
    218. Litvan I, Agid Y, Jankovic J, Goetz C, Brandel JP, Lai EC, Wenning G, D'Olhaberriague L, Verny M, Chaudhuri KR, McKee A, Jellinger K, Bartko JJ, Mangone CA, Pearce RK. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology. 1996 Apr; 46(4):922-30. PMID: 8780065.
      View in: PubMed
    219. Litvan I, Hauw JJ, Bartko JJ, Lantos PL, Daniel SE, Horoupian DS, McKee A, Dickson D, Bancher C, Tabaton M, Jellinger K, Anderson DW. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol. 1996 Jan; 55(1):97-105. PMID: 8558176.
      View in: PubMed
    220. Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y. Progressive supranuclear palsy: a clinicopathological study of 21 cases. Acta Neuropathol. 1996; 91(4):427-31. PMID: 8928621.
      View in: PubMed
    221. Grafman J, Litvan I, Stark M. Neuropsychological features of progressive supranuclear palsy. Brain Cogn. 1995 Aug; 28(3):311-20. PMID: 8546857.
      View in: PubMed
    222. Litvan I, Sirigu A, Toothman J, Grafman J. What can preservation of autobiographic memory after muscarinic blockade tell us about the scopolamine model of dementia? Neurology. 1995 Feb; 45(2):387-9. PMID: 7854546.
      View in: PubMed
    223. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology. 1994 Nov; 44(11):2015-9. PMID: 7969952.
      View in: PubMed
    224. Litvan I, Blesa R, Clark K, Nichelli P, Atack JR, Mouradian MM, Grafman J, Chase TN. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy. Ann Neurol. 1994 Jul; 36(1):55-61. PMID: 8024262.
      View in: PubMed
    225. Litvan I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl. 1994; 42:69-78. PMID: 7964698.
      View in: PubMed
    226. Litvan I. Cholinergic approaches to the treatment of progressive supranuclear palsy. J Neural Transm Suppl. 1994; 42:275-81. PMID: 7964692.
      View in: PubMed
    227. Litvan I, Berrettini WH, Atack JR, Chase TN. CSF galanin and neuropeptide Y immunoreactivity in progressive supranuclear palsy. Acta Neurol Scand. 1992 Aug; 86(2):204-6. PMID: 1384261.
      View in: PubMed
    228. Grafman J, Litvan I, Massaquoi S, Stewart M, Sirigu A, Hallett M. Cognitive planning deficit in patients with cerebellar atrophy. Neurology. 1992 Aug; 42(8):1493-6. PMID: 1641142.
      View in: PubMed
    229. Atack JR, Litvan I, Thal LJ, May C, Rapoport SI, Chase TN. Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine. J Neurol Neurosurg Psychiatry. 1991 Sep; 54(9):832-5. PMID: 1955905; PMCID: PMC1014527.
    230. Johnson R, Litvan I, Grafman J. Progressive supranuclear palsy: altered sensory processing leads to degraded cognition. Neurology. 1991 Aug; 41(8):1257-62. PMID: 1866015.
      View in: PubMed
    231. Litvan I, Mohr E, Williams J, Gomez C, Chase TN. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1991 Jan; 54(1):25-9. PMID: 2010755; PMCID: PMC1014293.
    232. Kertzman C, Robinson DL, Litvan I. Effects of physostigmine on spatial attention in patients with progressive supranuclear palsy. Arch Neurol. 1990 Dec; 47(12):1346-50. PMID: 2252453.
      View in: PubMed
    233. Mohr E, Juncos J, Cox C, Litvan I, Fedio P, Chase TN. Selective deficits in cognition and memory in high-functioning parkinsonian patients. J Neurol Neurosurg Psychiatry. 1990 Jul; 53(7):603-6. PMID: 2391526; PMCID: PMC488138.
    234. Grafman J, Litvan I, Gomez C, Chase TN. Frontal lobe function in progressive supranuclear palsy. Arch Neurol. 1990 May; 47(5):553-8. PMID: 2334303.
      View in: PubMed
    235. Grafman J, Weingartner H, Newhouse PA, Thompson K, Lalonde F, Litvan I, Molchan S, Sunderland T. Implicit learning in patients with Alzheimer's disease. Pharmacopsychiatry. 1990 Mar; 23(2):94-101. PMID: 2339182.
      View in: PubMed
    236. Litvan I, Gomez C, Atack JR, Gillespie M, Kask AM, Mouradian MM, Chase TN. Physostigmine treatment of progressive supranuclear palsy. Ann Neurol. 1989 Sep; 26(3):404-7. PMID: 2802540.
      View in: PubMed
    237. Litvan I, Grafman J, Gomez C, Chase TN. Memory impairment in patients with progressive supranuclear palsy. Arch Neurol. 1989 Jul; 46(7):765-7. PMID: 2742547.
      View in: PubMed
    238. Litvan I, Grafman J, Vendrell P, Martinez JM, Junqué C, Vendrell JM, Barraquer-Bordas JL. Multiple memory deficits in patients with multiple sclerosis. Exploring the working memory system. Arch Neurol. 1988 Jun; 45(6):607-10. PMID: 3369966.
      View in: PubMed
    239. Litvan I, Grafman J, Vendrell P, Martinez JM. Slowed information processing in multiple sclerosis. Arch Neurol. 1988 Mar; 45(3):281-5. PMID: 3341952.
      View in: PubMed